Device Trial Radar · NCT07357480
Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
63
Actual
Start
Jan 14, 2026
Primary completion
Jun 7, 2026
Study completion Jul 16, 2026
Sponsor
- Lead sponsor
- Istanbul University - CerrahpasaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 22, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to investigate the effect of target-controlled infusion using the Eleveld pharmacokinetic model compared with manually controlled total intravenous anesthesia on the incidence of postoperative delirium in patients undergoing supratentorial surgery. Propofol and remifentanil are administered using either target-controlled or manual infusion techniques according to the study protocol. Secondary objectives include comparisons of intraoperative anesthetic consumption, hemodynamic responses, recovery profiles, postoperative pain, and postoperative nausea and vomiting between the two anesthesia strategies. The study seeks to evaluate whether target-controlled infusion provides improved anesthetic management and postoperative outcomes compared with manual total intravenous anesthesia.
Conditions
- Postoperative Delirium (POD)
- Postoperative Pain
- PONV
- Burst Suppression
- Recovery Period, Anesthesia
Interventions
Target Controlled InfusionDevice
Total Intravenous Anesthesia (TIVA) will be administered using an infusion pump (e.g., BeneFusion nSP) equipped with the Eleveld pharmacokinetic model. Propofol will be initiated at a target concentration of 3-3.5 µg/ml, and Remifentanil at 2-3 ng/ml (effect-site targeting). The "opioid present" option will be selected for the propofol model. Doses will be titrated to maintain a Bispectral Index (BIS) value between 40-60 throughout the surgery.
Total Intravenous Anesthesia(TIVA)Device
Total Intravenous Anesthesia (TIVA) will be administered via manual titration. Induction will be performed with 20 mg propofol boluses based on EEG changes on the BIS monitor, followed by a remifentanil infusion of 0.1 µg/kg/min. Maintenance doses will be manually adjusted by the anesthesiologist to maintain a Bispectral Index (BIS) value between 40-60 and hemodynamic stability.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Postoperative DeliriumTime frame: Postoperative 72 hours
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine
Istanbul, Bakırköy, Turkey (Türkiye)
Cerrahpaşa Tıp Fakültesi Murat Dilmener Hastanesi
Istanbul, Istanbul, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.